Company Information
USD
7.43
- (4.7%)
NASDAQ:PRTA, PROTHENA CORPORATION PLC
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
Address
77 Sir John Rogerson’s Quay
Block C
Grand Canal Docklands
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Daniel G. Welch
Director
Mr. Oleg Nodelman
Director
Mr. Tran B. Nguyen
CFO/Chief Strategy Officer
Ms. Helen S. Kim
Director
Mr. Richard T. Collier
Director
Dr. Dennis J. Selkoe, M.D.
Director
Dr. Lars G. Ekman, M.D.,PhD
Chairman of the Board/Director
Mr. Shane M. Cooke
Director
Ms. Carol D. Karp
Other Executive Officer
Ms. Karin L. Walker
Chief Accounting Officer
Dr. Gene G. Kinney, PhD
CEO/Director/President
Dr. K. Anders O. Harfstrand, M.D.,PhD
Director
Mr. Wagner M. Zago
Chief Scientific Officer
Ms. Paula K. Cobb
Director
Mr. Michael J. Malecek
Chief Legal Officer/Secretary
Mr. Brandon S. Smith
COO
Mr. Hideki Garren
Chief Medical Officer
Dr. William H. Dunn, Jr
Director
Dr. Radhika Tripuraneni, M.D.,M.P.H.
Other Executive Officer
Ownership
Institution Holdings
EcoR1 Capital, LLC
11,584,280 (21.564%)
FMR Inc
8,049,796 (14.985%)
FMR LLC
5,264,847 (9.811%)
T. Rowe Price Associates, Inc.
4,237,351 (7.888%)
Fidelity Management & Research Company LLC
3,914,684 (7.287%)
BlackRock Inc
3,770,650 (7.019%)
Fidelity Management Trust Company
3,060,678 (5.697%)
State Street Corporation
2,758,564 (5.135%)
Wellington Management Company LLP
2,594,102 (4.829%)
HHG PLC
2,035,984 (3.790%)
Individual Holdings
Dr. Gene G. Kinney, PhD
12,793 (0.024%)
Mr. Tran B. Nguyen
3,200 (0.006%)
Dr. Dennis J. Selkoe, M.D.
2,845 (0.005%)
Mr. Richard T. Collier
1,219 (0.002%)
Dr. Lars G. Ekman, M.D.,PhD
243 (0.001%)
Funds Holdings
Fidelity Growth Company Commingled Pool
3,125,259 (5.818%)
Fidelity Growth Company Fund
2,295,765 (4.274%)
SPDR® S&P Biotech ETF
1,947,697 (3.626%)
Vanguard Health Care Fund
1,782,583 (3.318%)
US Small-Cap Growth II Equity Comp
1,763,914 (3.284%)
T. Rowe Price New Horizons Fund
1,763,914 (3.284%)
iShares Russell 2000 ETF
1,031,979 (1.921%)
T. Rowe Price Health Sciences Fund
847,697 (1.578%)
Fidelity Growth Company K6 Fund
815,160 (1.517%)
Fidelity Series Growth Company Fund
741,805 (1.381%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
